Press release
MRNA Based Vaccines and Therapeutics Market Forecast 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight
MRNA Based Vaccines and Therapeutics Market
The MRNA Based Vaccines and Therapeutics market report presents the latest information on the treatment approaches, upcoming drugs, the market share of various therapies, and the projected size of the MRNA Based Vaccines and Therapeutics market from 2019 to 2032. The report focuses on seven major markets and provides insights into the current treatment practices and algorithms for MRNA Based Vaccines and Therapeutics. It also examines the factors driving the market, the obstacles faced, and the unmet medical needs in order to identify promising opportunities and evaluate the potential of the MRNA Based Vaccines and Therapeutics market.
Discover which therapies are expected to grab the MRNA Based Vaccines and Therapeutics Market Share @ MRNA Based Vaccines and Therapeutics Market Outlook - https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the MRNA Based Vaccines and Therapeutics Market Report
• In March 2025, GlaxoSmithKline announced a study is to assess the safety and immune response of GlaxoSmithKlines (GSK) messenger RNA (mRNA)-based multivalent vaccine (GSK4382276A) candidate against influenza, administered in healthy younger adults (YA) and older adults (OA).
• In March 2025, Sanofi conducted a study is to evaluate the safety and immunogenicity of a human metapneumovirus (hMPV) / respiratory syncytial virus (RSV) mRNA vaccine candidate encapsulated in a lipid nanoparticle (LNP) based formulation (hereafter referred to as hMPV/RSV vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by hMPV and/or RSV among adults aged 60 years and older.
• The increase in MRNA Based Vaccines and Therapeutics Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the MRNA Based Vaccines and Therapeutics Market is anticipated to witness growth at a considerable CAGR.
• The leading MRNA Based Vaccines and Therapeutics Companies such as Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE, AIM Vaccine Corporation, Charoen Pokphand Group, Argos Therapeutics Inc., Sanofi, Kernal Biologics Inc, and others, and others
• Promising MRNA Based Vaccines and Therapeutics Pipeline Therapies such as VX-522, RCT1100, mRNA-4157, REM-422, scAAV9.U7.ACCA, PF-06651600, STP705, PTW-002 10, Enzalutamide, JCXH-221, BIVV003, bbT369, HBI-002, SLN124, STC-15, BNT112, AGMB-129, ALN-HSD, JNJ-55308942, AZD8701, BBV152, MCLA-158, SAR441000, ITI-1000, and others.
Stay ahead in the MRNA Based Vaccines and Therapeutics Market with DelveInsight's Strategic Report @ MRNA Based Vaccines and Therapeutics Market Outlook- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
MRNA Based Vaccines and Therapeutics Epidemiology Segmentation in the 7MM
The epidemiology section of MRNA Based Vaccines and Therapeutics offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
• Total Incident Cases of Shortlisted Indications for mRNA Therapy for Oncology
• Total Indication-wise Eligible Cases for mRNA Therapy for Oncology
• Indication-wise Treated Cases of mRNA Therapy for Oncology
Download the report to understand which factors are driving MRNA Based Vaccines and Therapeutics Epidemiology trends @ MRNA Based Vaccines and Therapeutics Prevalence- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
MRNA Based Vaccines and Therapeutics Drugs Market
The MRNA Based Vaccines and Therapeutics Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying MRNA Based Vaccines and Therapeutics signaling in MRNA Based Vaccines and Therapeutics are likely to uncover new therapeutic targets and further expand treatment options for patients.
MRNA Based Vaccines and Therapeutics Treatment Market Landscape
The MRNA Based Vaccines and Therapeutics treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of MRNA Based Vaccines and Therapeutics has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To learn more about MRNA Based Therapeutics treatment guidelines, visit @ MRNA Based Therapeutics Treatment Market Landscape- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
MRNA-Based Therapeutics Pipeline Therapies and Companies
• VX-522: Vertex Pharmaceuticals Incorporated
• RCT1100: ReCode Therapeutics
• mRNA-4157: ModernaTX, Inc./Merck Sharp & Dohme LLC
• REM-422: Remix Therapeutics
• scAAV9.U7.ACCA: Audentes Therapeutics
• PF-06651600: Pfizer
• STP705: Sirnaomics
• PTW-002 10: Phoenicis Therapeutics
• Enzalutamide: Astellas Pharma US, Inc.
• JCXH-221: Immorna Biotherapeutics, Inc./ICON plc
• BIVV003: Sangamo Therapeutics
• bbT369: 2seventy bio
• HBI-002: Hillhurst Biopharmaceuticals, Inc.
• SLN124: Silence Therapeutics plc
• STC-15: STORM Therapeutics LTD
• BNT112: BioNTech SE
• AGMB-129: Agomab Therapeutics NV
• ALN-HSD: Alnylam Pharmaceuticals
• JNJ-55308942: Janssen Pharmaceutica N.V.
• AZD8701: AstraZeneca
• BBV152: Ocugen
• MCLA-158: Merus N.V.
• SAR441000: Sanofi
• ITI-1000: Immunomic Therapeutics
MRNA Based Therapeutics Market Outlook
The report's outlook on the MRNA Based Vaccines and Therapeutics market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing MRNA Based Vaccines and Therapeutics therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed MRNA Based Therapeutics drug and late-stage pipeline therapy.
MRNA Based Therapeutics Drugs Uptake
The drug chapter of the MRNA Based Therapeutics report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to MRNA Based Vaccines and Therapeutics.
MRNA Based Vaccines and Therapeutics Market Dynamics
The dynamics of the global mRNA-based therapeutics market are expected to change in the coming years. Several mRNA-based vaccine candidates currently in pre-clinical and clinical phases of development are poised to drive the mRNA-based vaccines and therapeutics market in upcoming years, as the field of mRNA-based therapeutics spans from protein replacement therapy and gene editing to vaccination, and continued advancements in mRNA formulation and delivery using different nanomaterials hold the potential to improve the wider use of mRNA for the treatment and prevention of infectious diseases and cancers.
Major MRNA Based Therapeutics Companies
Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE, AIM Vaccine Corporation, Charoen Pokphand Group, Argos Therapeutics Inc., Sanofi, Kernal Biologics Inc, and others, and others
Learn more about the FDA-approved drugs for MRNA Based Vaccines and Therapeutics @ Drugs for MRNA Based Vaccines and Therapeutics Treatment- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the MRNA Based Vaccines and Therapeutics Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• MRNA Based Vaccines and Therapeutics Companies- Pfizer Inc. (NYSE: PFE), BioNTech SE (NASDAQ: BNTX), Moderna, Inc. (NASDAQ: MRNA), Gennova Biopharmaceuticals Limited, GSK plc (LSE: GSK), Daiichi Sankyo (TSE: 4568), Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE (NASDAQ: CVAC), AIM Vaccine Corporation (HKEX: 06660), Charoen Pokphand Group, Argos Therapeutics Inc., Sanofi (EPA: SAN), Kernal Biologics Inc., and others.
• MRNA Based Vaccines and Therapeutics Pipeline Therapies- VX-522, RCT1100, mRNA-4157, REM-422, scAAV9.U7.ACCA, PF-06651600, STP705, PTW-002 10, Enzalutamide, JCXH-221, BIVV003, bbT369, HBI-002, SLN124, STC-15, BNT112, AGMB-129, ALN-HSD, JNJ-55308942, AZD8701, BBV152, MCLA-158, SAR441000, ITI-1000, and others.
• MRNA Based Vaccines and Therapeutics Market Dynamics: MRNA Based Vaccines and Therapeutics Market Drivers and Barriers
• MRNA Based Vaccines and Therapeutics Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about MRNA Based Therapeutics Drugs in development @ MRNA Based Vaccines and Therapeutics Clinical Trials Assessment- https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Key Insights
2. MRNA Based Vaccines and Therapeutics Executive Summary
3. MRNA Based Vaccines and Therapeutics Competitive Intelligence Analysis
4. MRNA Based Vaccines and Therapeutics: Market Overview at a Glance
5. MRNA Based Vaccines and Therapeutics: Disease Background and Overview
6. Patient Journey
7. MRNA Based Vaccines and Therapeutics Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. MRNA Based Vaccines and Therapeutics Unmet Needs
10. Key Endpoints of MRNA Based Vaccines and Therapeutics Treatment
11. MRNA Based Vaccines and Therapeutics Marketed Products
12. MRNA Based Vaccines and Therapeutics Emerging Therapies
13. MRNA Based Vaccines and Therapeutics: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: MRNA Based Vaccines and Therapeutics Market Outlook
16. Access and Reimbursement Overview of MRNA Based Vaccines and Therapeutics
17. KOL Views
18. MRNA Based Vaccines and Therapeutics Market Drivers
19. MRNA Based Vaccines and Therapeutics Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Related Reports:
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Neuroprosthetics Market: https://www.delveinsight.com/blog/neuroprosthetics-market-analysis
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Dysthymia Market: https://www.delveinsight.com/report-store/persistent-depressive-disorder-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release MRNA Based Vaccines and Therapeutics Market Forecast 2032: Clinical Trials, EMA, PDMA, FDA Approvals, Medication, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight here
News-ID: 4064714 • Views: …
More Releases from DelveInsight Business Research
Murine Double Minute 2 (MDM2) Inhibitor Pipeline 2025: MOA and ROA Insights, Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Murine Double Minute 2 (MDM2) Inhibitor pipeline constitutes key companies continuously working towards developing Murine Double Minute 2 (MDM2) Inhibitor treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Murine Double Minute 2 (MDM2) Inhibitor Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario…
Diabetic Foot Ulcers Market to Expand Significantly by 2034, States DelveInsight …
The Diabetic Foot Ulcers market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Diabetic Foot Ulcers pipeline products will significantly revolutionize the Diabetic Foot Ulcers market dynamics.
DelveInsight's "Diabetic Foot Ulcers Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Diabetic Foot Ulcers, historical and forecasted epidemiology as well as the Diabetic Foot…
Marginal Zone Lymphoma Market Growth Projections 2024-2034: DelveInsight Analysi …
DelveInsight's "Marginal Zone Lymphoma Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Marginal Zone Lymphoma, historical and forecasted epidemiology as well as the Marginal Zone Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Marginal Zone Lymphoma market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Marginal Zone Lymphoma…
Treatment Resistant Depression Pipeline 2025: Therapies Under Investigation, Cli …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Treatment Resistant Depression pipeline constitutes 25+ key companies continuously working towards developing 25+ Treatment Resistant Depression treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Treatment Resistant Depression Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Treatment Resistant…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
